Diaceutics PLC Market Cap ($2.10 Million)
Market Cap & Net Worth: Diaceutics PLC (DXRX)
Diaceutics PLC market cap. Diaceutics PLC (LSE:DXRX) has a market capitalization of $2.10 Million (GBX17.27 Billion) as of October 31, 2026. Listed on the LSE stock exchange, this UK-based company holds position #30003 globally and #680 in its home market, demonstrating a 2.26% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Diaceutics PLC's stock price GBX203.50 by its total outstanding shares 84861326 (84.86 Million).
Diaceutics PLC Market Cap History (2019–2026)
Diaceutics PLC market cap history from 2019 to 2026. Data shows growth from $1.05 Million to $2.10 Million (10.44% CAGR). Check latest Diaceutics PLC stock price today for real-time trading data and today's change.
Index Memberships
Diaceutics PLC is a constituent of 1 market index:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
FTSE AIM All Share Index
FTAI
|
$993.18 Million | 0.21% | #98 of 722 |
Weight: Diaceutics PLC's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Diaceutics PLC Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Diaceutics PLC's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Also see Diaceutics PLC cash flow conversion for how efficiently the company converts equity into cash flow.
Latest Price to Sales (P/S) Ratio
0.03x
Diaceutics PLC's market cap is 0.03 times its annual revenue
Latest Price to Earnings (P/E) Ratio
13.62x
Diaceutics PLC's market cap is 13.62 times its annual earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2019 | $1.05 Million | $13.44 Million | $398.00K | 0.08x | 2.65x |
| 2020 | $1.38 Million | $12.70 Million | $263.00K | 0.11x | 5.24x |
| 2021 | $1.05 Million | $13.94 Million | $561.00K | 0.08x | 1.88x |
| 2022 | $779.55K | $19.50 Million | $724.00K | 0.04x | 1.08x |
| 2023 | $898.29K | $23.70 Million | -$1.75 Million | 0.04x | N/A |
| 2024 | $1.30 Million | $32.16 Million | -$1.70 Million | 0.04x | N/A |
| 2025 | $1.32 Million | $38.44 Million | $97.00K | 0.03x | 13.62x |
Competitor Companies of DXRX by Market Capitalization
Companies near Diaceutics PLC in the global market cap rankings as of October 31, 2026. See DXRX net asset quality index to understand what proportion of total assets are financed by equity.
Key companies related to Diaceutics PLC by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #719 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1627 globally with a market cap of $14.50 Billion USD ( AU$20.50 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2005 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2067 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #719 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $312.96 |
| #1627 | Pro Medicus Ltd | AU:PME | $14.50 Billion | AU$196.20 |
| #2005 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $72.22 |
| #2067 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $66.89 |
Market Capitalization of Diaceutics PLC (2019–2026)
Market capitalization of Diaceutics PLC from 2019 to today. Between 2019 and today, Diaceutics PLC's market cap moved from $1.05 Million to $ 2.10 Million, with a yearly change of 10.44%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | GBX2.10 Million | +58.98% |
| 2025 | GBX1.32 Million | +1.99% |
| 2024 | GBX1.30 Million | +44.25% |
| 2023 | GBX898.29K | +15.23% |
| 2022 | GBX779.55K | -25.98% |
| 2021 | GBX1.05 Million | -23.60% |
| 2020 | GBX1.38 Million | +30.88% |
| 2019 | GBX1.05 Million | -- |
End of Day Market Cap According to Different Sources
On Oct 31st, 2026 the market cap of Diaceutics PLC was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $2.10 Million USD |
| MoneyControl | $2.10 Million USD |
| MarketWatch | $2.10 Million USD |
| marketcap.company | $2.10 Million USD |
| Reuters | $2.10 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Diaceutics PLC
Diaceutics PLC, a diagnostic commercialization company, provides data, data analytics, and implementation services for pharma and biotech companies. The company offers DXRX, a diagnostic commercialization platform for precision medicine that integrates multiple pipelines of diagnostic testing data from a network of laboratories. It also provides DXRX data solutions, including DXRX Signal, that en… Read more